|Product:||Contrast Agent for Targeted In Vivo Imaging. Offered exclusively by MediLumine and co-developed with Cytodiagnostics Inc., a leader in manufacture of gold nanoparticles for Biology and Medicine.|
Mvivo AuNHS kit has been optimized for high efficiency conjugation of proteins and other primary amine-containing ligands to gold nanoparticle suspensions with concentrations suitable for targeted in vivo imaging. The kit contains ready-to-use pre-made mixtures. No activation or manipulation of the gold nanoparticles is required prior to conjugation. Simply mix your protein with the pre-activated NHS ester gold nanoparticles supplied in the kit.
|Application:||Targeted microCT Imaging|
|Kit Components:||Kit component 1 vial of Mvivo AuNHS (mini), 1 vial of Mvivo AuNHS (maxi), 3 Bottles of Reaction Buffers, 1 Mirad Device, 1 Mirad Buffer|
|Particle size:||14 ±2 nm|
|Miriad™ is a trademark of MedMira Inc.|
Two Step Solution for Dose Preparation:
Verify your protein’s (or primary amine containing ligand) conjugation to Mvivo AuNHS using Miriad™ rapid test development kit — kit contains enough material to verify three different protein/ligands (or three different concentrations).
Scale-up production of conjugate at an optical density and concentration that is suitable for targeted in vivo imaging.